Crucial role of FLT3 ligand in immune reconstitution following bone marrow transplantation and high dose chemotherapy.

被引：0
|
作者：
Buza-Vidas, Natalija [1 ]
Cheng, Min [1 ]
Duarte, Sara [1 ]
Jacobsen, Sten Eirik W. [1 ]
Sitnicka, Ewa [1 ]
机构：
[1] Lund Univ, Strateg Res Ctr Stem Cell Biol & Cell Therapy, Hematopoiet Stem Cell Lab, Lund, Sweden
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3208.3208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3208
引用
收藏
页码：915A / 916A
页数：2
相关论文
共 50 条
  • [31] ALTERED IMMUNOLOGICAL RECONSTITUTION FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BONE-MARROW SUPPORT (ABMS)
    OLSEN, GA
    GOCKERMAN, JP
    BAST, RC
    PETERS, WP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 184 - 184
  • [32] INFLAMMATORY PERIPHERAL NEUROPATHY FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BASHIR, RM
    BIERMAN, P
    MCCOMB, R
    BONE MARROW TRANSPLANTATION, 1992, 10 (03) : 305 - 306
  • [33] Ex-vivo expansion of bone marrow cells for hematopoietic reconstitution following high dose chemotherapy for breast cancer
    Bachier, C
    Gokmen, E
    Teale, J
    Lanzkron, S
    Hougham, M
    Meneghetti, C
    Nanez, A
    Huerta, J
    Childs, C
    Franklin, W
    Douville, J
    Weber, S
    Armstrong, D
    LeMaistre, CF
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 702 - 702
  • [34] Sex steroid ablation enhances immune reconstitution following allogeneic bone marrow transplantation.
    Goldberg, GL
    Alpdogan, O
    Muriglan, SJ
    Willis, LM
    Greenberg, AS
    Boyd, RL
    van den Brink, MRM
    BLOOD, 2002, 100 (11) : 406A - 406A
  • [35] IMMUNE SYSTEM RECONSTITUTION FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MAN - MULTIPARAMETER ANALYSIS
    ELFENBEIN, GJ
    ANDERSON, PN
    HUMPHREY, RL
    MULLINS, GM
    SENSENBRENNER, LL
    WANDS, JR
    SANTOS, GW
    TRANSPLANTATION PROCEEDINGS, 1976, 8 (04) : 641 - 646
  • [36] IMMUNE RECONSTITUTION FOLLOWING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ROBERTS, MM
    TO, LB
    GILLIS, D
    MUNDY, J
    RAWLING, C
    NG, K
    JUTTNER, CA
    BONE MARROW TRANSPLANTATION, 1993, 12 (05) : 469 - 475
  • [37] Radioprotection by FLT3 ligand combined with G-CSF following high dose total body irradiation in rabbits.
    WodnarFilipowicz, A
    John, L
    Baldomero, H
    Speck, B
    Lyman, SD
    Gratwohl, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 637 - 637
  • [38] Donor treatment with Flt3 ligand augments microchimerism in tacrolimus-immunosuppressed allogeneic bone marrow recipients
    Antonysamy, MA
    Morelli, AE
    O'Connell, PJ
    Zurowski, NB
    Takayama, T
    Thomson, AW
    TRANSPLANTATION, 1999, 67 (07) : S47 - S47
  • [39] Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus
    Iyengar, AR
    Bonham, CA
    Antonysamy, MA
    Subbotin, VM
    Khanna, A
    Murase, N
    Rao, AS
    Starzl, TE
    Thomson, AW
    TRANSPLANTATION, 1997, 63 (09) : 1193 - 1199
  • [40] Generation of murine dendritic cells from FLT3 ligand-supplemented bone marrow cultures.
    Brasel, K
    Smith, JL
    Maliszewski, CR
    BLOOD, 1999, 94 (10) : 213A - 213A
12345